Identification of Submicromolar Sphingomyelin Synthase Inhibitors by Rational Design

来源 :2016年长三角药物化学研讨会 | 被引量 : 0次 | 上传用户:xfengwujiutian
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Sphingomyelin synthase is a proposed potential therapeutic target for atherosclerosis1,obesity and insulin resistance2.Sphingomyelin(SM) is the most abundant sphingolipids in the cell,with ubiquitous distribution within mammalian tissues,playing an important role in cell function.
其他文献
会议
会议
会议
会议
会议
会议
The proteasome in ubiquitin-proteasome system (UPS) has been validated as an attractive therapeutic target for cancer therapy since FDA approved Bortezomib,Carfilzomib and Ixazomib for the treatment o
会议
A small molecules library with structure diversity was constructed through diversity-oriented synthesis (DOS) strategy.1 Seven novel scaffolds were quickly synthesized through transition metal catalyz
会议